Ann: Investor Presentation - September 2017, page-2

Nice presentation, Im in on MyFiziq and have been buying over the past few days. Massive Upside.

- Measures over 39,000 data points of a persons body to detect changes in physique over time. More accurate and consistent than any other method available, digital or manual.
- Fully funded. 2.7M Cash + Expected 1.5M from JV Partner
- JV Partner with a Singaporean Company who have committed $5M to form a new company 'Body Composite'. Working on a medical grade application which will ultimately aim to replace the inefficient BMI scale to be used in health and insurance settings. Trials are underway in Western Australia (product already works).
- T20 Hold 72% of the Shares on Issue
- IP Protected. Whilst the technology patent is broad. They have internal tech officers who have built the algorithms.
- Launching B2B solution early next year essentially white-labelling their product. This is the real money maker. They have initiated a partnership with Fitocracy, a leading fitness coaching app in the US. Expecting annual revenues around $9M USD with revenues expected to begin Q1 2018. Fitocracy have 2M active users and MYQ believe they will be able to capture half a million subscribers on their platform. Its a perfect complementary offering. Currently working on a definitive agreement expected by the EOY.
- Agressive Perfomance Milestones set

The IPO at 20c was needed to build out the app and test a soft launch. With the recent developments in particular the JV partner, entrance in the medical field and first US partnership, MYQ sit in a great FA position.

Limited downside and a great set up from small market valuation. As always DYOR.